BRIEF-Al Majed For Oud Updates On MOU To Buy Al Safa Pharmaceuticals

ALMAJED OUD

ALMAJED OUD

4165.SA

0.00

June 14 (Reuters) - Al Majed for Oud Company SJSC 4165.SE:

  • AL MAJED FOR OUD COMPANY SJSC - UPDATES ON MOU TO BUY AL SAFA PHARMACEUTICALS

  • AL MAJED FOR OUD - PARTIES AGREED ON AN ENTERPRISE VALUE FOR TARGET GROUP OF SAR 392 MILLION

  • AL MAJED FOR OUD - ENTRY INTO AN NBO BETWEEN AL MAJED FOR OUD AND THE SELLERS

  • AL MAJED FOR OUD - CONSIDERATION IS INTENDED TO BE PAID THROUGH COMBINATION OF CASH AND NEW SHARES IN AL MAJED FOR OUD

  • AL MAJED FOR OUD - ALLOCATION BETWEEN SHARE CONSIDERATION AND CASH CONSIDERATION HAS NOT BEEN AGREED

  • AL MAJED FOR OUD - PARTIES AGREED TO VALUE AL MAJED FOR OUD’S SHARES BASED ON VWAP, BEING SAR 151.01 PER SHARE, FOR PORTION OF CONSIDERATION TO BE SETTLED THROUGH ISSUANCE OF NEW SHARES

  • AL MAJED FOR OUD - NBO WILL TERMINATE IF BINDING ACQUISITION AGREEMENT IS NOT EXECUTED WITHIN SIX MONTHS

Source text: ID:nSSE7XHrKn

Further company coverage: 4165.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.